NTpharma
NTpharma provides GMP production of nanovaccines and biopharmaceuticals containing carbohydrate binders.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed NTpharma Information
Geographic Data
Address:
City: Moscow
State: Moscow City
Zip:
Country: Russian Federation
Financial Info
Stage:
series unknown
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
NTpharma provides GMP production of nanovaccines and biopharmaceuticals containing carbohydrate binders. The project provides for building a facility for production of vaccines and pharmaceuticals in the municipal area of Pereslavl’-Zalessky, 150 kilometers (85 miles) northeast of Moscow. The project aims at production of new generation vaccines, including a polyvalent human flu vaccine, and pharmaceuticals for detoxification in oncological therapy and for treatment of amyotrophic lateral sclerosis (ALS/Lou Gehrig’s disease). NTpharma’s technology allows to reduce by half the time required for culturing and production of the vaccine. This advantage is vital when dealing with vaccines for pandemic flu strains spreading rapidly all over the world.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
